Anat Gershoni

630 total citations
5 papers, 306 citations indexed

About

Anat Gershoni is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Anat Gershoni has authored 5 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Cancer Research. Recurrent topics in Anat Gershoni's work include Hippo pathway signaling and YAP/TAZ (3 papers), Cancer, Lipids, and Metabolism (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). Anat Gershoni is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (3 papers), Cancer, Lipids, and Metabolism (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). Anat Gershoni collaborates with scholars based in Israel, United States and United Kingdom. Anat Gershoni's co-authors include Moshe Oren, Ohad Tarcic, Eran Segal, Debora S. Marks, Thomas A. Hopf, Eran Kotler, Maya Lotan‐Pompan, Ron Rotkopf, Yael Aylon and Randy L. Johnson and has published in prestigious journals such as Genes & Development, Molecular Cell and Molecular Oncology.

In The Last Decade

Anat Gershoni

5 papers receiving 303 citations

Peers

Anat Gershoni
Comparison fields: 5 of 52
  • Molecular Biology 184
  • Cancer Research 116
  • Oncology 101
  • Cell Biology 92
  • Genetics 37
Replace Kacey VanderVorst with:
Kacey VanderVorst United States
Maud Magdeleine France
Daniel E. Foxler United Kingdom
Laura Curti Italy
Qianze Dong China
Zeng-Quan Yang United States
Anja Hohmeyer Germany
Lawrence Chinn United States
Kacey VanderVorst United States View profile →
Citations per field, relative to Anat Gershoni
Anat Gershoni · 1×
Citations per year, relative to Anat Gershoni
Anat Gershoni · 1×

Countries citing papers authored by Anat Gershoni

Since Specialization
Citations

This map shows the geographic impact of Anat Gershoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anat Gershoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anat Gershoni more than expected).

Fields of papers citing papers by Anat Gershoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anat Gershoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anat Gershoni. The network helps show where Anat Gershoni may publish in the future.

Co-authorship network of co-authors of Anat Gershoni

This figure shows the co-authorship network connecting the top 25 collaborators of Anat Gershoni. A scholar is included among the top collaborators of Anat Gershoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anat Gershoni. Anat Gershoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
# Work Indexed citations
1 6
2 181
3 26
4 90
5 3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026